Explore India's leading biotech companies driving innovation in healthcare and beyond.
India’s biotech industry, driven by government initiatives like "Make in India," spans biopharmaceuticals, bio-services, bio-agriculture, bio-industry, and bioinformatics. With a market valuation projected to exceed $150 billion by 2025, it is a key player in global innovation.
Market Cap: ₹44,001.99 Crore Headquartered in Bangalore, Biocon Ltd. is a pioneer in biopharmaceuticals, specializing in biosimilars and research-driven therapies. Renowned for its innovative solutions in diabetes and oncology care. Data as of 31st December 2024. Source – NSE
Market Cap: ₹23,538.65 Crore Ahmedabad-based Concord Biotech excels in fermentation-based biopharmaceuticals, serving global markets with APIs for immunosuppressants and oncology treatments. Data as of 31st December 2024. Source – NSE
Market Cap: ₹6,487.19 Crore Sun Pharma Advanced Research, located in Mumbai, focuses on new chemical entities and innovative drug delivery systems, enhancing therapeutic efficacy. Data as of 31st December 2024. Source – NSE
Market Cap: ₹2,152.73 Crore Dehradun-based Windlas Biotech specializes in contract development and manufacturing, supporting global pharmaceutical brands with high-quality formulations. Data as of 31st December 2024. Source – NSE
Market Cap: ₹58.25 Crore Focused on affordable healthcare, ANG Lifesciences, headquartered in Amritsar, manufactures injectable formulations for domestic and international markets.
Market Cap: ₹55.11 Crore Based in Hyderabad, Vivo Biotech is a leader in preclinical contract research and biologics development, catering to global pharmaceutical companies. Data as of 31st December 2024. Source – NSE
India’s biotech sector is thriving, fueled by innovation, R&D, and supportive policies. Companies like Biocon, Concord Biotech, and Windlas Biotech are leading this charge with groundbreaking contributions. Data as of 31st December 2024. Source – NSE